Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-26, Stock:NVS, The news for the past five days is as follows:
2019-03-19: NEWS1: Tilray Lags Behind Its Marijuana Peers.NEWS2: Tilray Lags Behind Its Marijuana Peers.NEWS3: Tilray Earnings Impressive: More Reasons to Buy Marijuana ETFs.NEWS4: Tilray Earnings Impressive: More Reasons to Buy Marijuana ETFs.NEWS5: Tilray Earnings Impressive: More Reasons to Buy Marijuana ETFs.NEWS6: 3 Blue Chip Stocks That Just Hit 52-Week Highs: Are They Buys?.NEWS7: 3 Blue Chip Stocks That Just Hit 52-Week Highs: Are They Buys?.NEWS8: 3 Blue-Chip Stocks That Just Hit 52-Week Highs: Are They Buys?.NEWS9: Tilray Inc (TLRY) Q4 2018 Earnings Conference Call Transcript.NEWS10: Alnylam's (ALNY) Impressive Pipeline Drives Share Price.NEWS11: Alnylam's (ALNY) Impressive Pipeline Drives Share Price.
2019-03-20: NEWS1: Major biotech landlord plants flag in East Bay with acquisition of Novartis site.NEWS2: Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan.NEWS3: Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan.NEWS4: Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision.NEWS5: Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision.NEWS6: Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision.NEWS7: Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan.
2019-03-21: NEWS1: Is Biogen a Bad-News Buy Now?.NEWS2: Cooper Companies' (COO) CooperVision Gains Momentum Globally.NEWS3: Cooper Companies' (COO) CooperVision Gains Momentum Globally.NEWS4: Cooper Companies' (COO) CooperVision Gains Momentum Globally.
2019-03-22: NEWS1: Conatus (CNAT) Declines on Failure of NASH Fibrosis Study.NEWS2: Biogen Stock Crashes on Termination of Alzheimer's Studies.NEWS3: Biogen Stock Crashes on Termination of Alzheimer's Studies.NEWS4: Biogen Stock Crashes on Termination of Alzheimer's Studies.NEWS5: Conatus Shares Fall By More Than 50% After Midstage Study Shows NASH Candidate Lagged Placebo.NEWS6: Novartis says listing of Alcon eye care business expected on April 9.NEWS7: Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook.
2019-03-25: NEWS1: Were Hedge Funds Right About Novartis AG  (NVS)?.NEWS2: Health Care Digest: Genentech's tumor-agnostic cancer drug, Novartis' East Bay option and more.NEWS3: Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook.

Answer: Rise